Conversion of Persistent Atrial Fibrillation After Radiofrequency Ablation by Ibutilide
- PMID: 28496723
- PMCID: PMC5153012
- DOI: 10.4022/jafib.500
Conversion of Persistent Atrial Fibrillation After Radiofrequency Ablation by Ibutilide
Abstract
Ablation of peristent AF remains challenging with questions unanswered about what the ideal next step after pulmonary venous isolation should be. Ibutilide is a highly effective class III agent for cardioversion of acute-onset atrial flutter and fibrillation, with limited clinical use due to risks of ventricular pro-arrhythmias. However, results from the on-going MAGIC-AF trial may re-invigorate its role in clinical electrophysiology as an invaluable adjunct to facilitate controlled substrate modification during ablation of persistent AF.
Figures

Similar articles
-
Single dose of ibutilide for conversion of persistent atrial fibrillation after radiofrequency ablation.Chin Med J (Engl). 2011 Mar;124(5):710-3. Chin Med J (Engl). 2011. PMID: 21518563
-
[Efficacy of ibutilide for cardioversion of persistent atrial fibrillation during radiofrequency ablation].Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Nov;39(11):1029-32. Zhonghua Xin Xue Guan Bing Za Zhi. 2011. PMID: 22336457 Clinical Trial. Chinese.
-
The modified stepwise ablation guided by low-dose ibutilide in chronic atrial fibrillation trial (The MAGIC-AF Study).Eur Heart J. 2016 May 21;37(20):1614-21. doi: 10.1093/eurheartj/ehw003. Epub 2016 Feb 4. Eur Heart J. 2016. PMID: 26850076 Clinical Trial.
-
Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.J Am Board Fam Med. 2011 Jan-Feb;24(1):86-92. doi: 10.3122/jabfm.2011.01.080096. J Am Board Fam Med. 2011. PMID: 21209348 Review.
-
Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.Ann Pharmacother. 1999 Jan;33(1):38-47. doi: 10.1345/aph.18097. Ann Pharmacother. 1999. PMID: 9972384 Review.
References
-
- Haïssaguerre M, Jaïs P, Shah D C, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 1998 Sep 03;339 (10):659–66. - PubMed
-
- Oral Hakan, Knight Bradley P, Tada Hiroshi, Ozaydin Mehmet, Chugh Aman, Hassan Sohail, Scharf Christoph, Lai Steve W K, Greenstein Radmira, Pelosi Frank, Strickberger S Adam, Morady Fred. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation. 2002 Mar 05;105 (9):1077–81. - PubMed
-
- Cappato Riccardo, Negroni Silvia, Pecora Domenico, Bentivegna Stefano, Lupo Pier Paolo, Carolei Adriana, Esposito Cristina, Furlanello Francesco, De Ambroggi Luigi. Prospective assessment of late conduction recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation. Circulation. 2003 Sep 30;108 (13):1599–604. - PubMed
-
- O'Neill Mark D, Wright Matthew, Knecht Sébastien, Jaïs Pierre, Hocini Mélèze, Takahashi Yoshihide, Jönsson Anders, Sacher Frédéric, Matsuo Seiichiro, Lim Kang Teng, Arantes Leonardo, Derval Nicolas, Lellouche Nicholas, Nault Isabelle, Bordachar Pierre, Clémenty Jacques, Haïssaguerre Michel. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur. Heart J. 2009 May;30 (9):1105–12. - PubMed
-
- Knecht Sébastien, Hocini Mélèze, Wright Matthew, Lellouche Nicolas, O'Neill Mark D, Matsuo Seiichiro, Nault Isabelle, Chauhan Vijay S, Makati Kevin J, Bevilacqua Michela, Lim Kang-Teng, Sacher Frederic, Deplagne Antoine, Derval Nicolas, Bordachar Pierre, Jaïs Pierre, Clémenty Jacques, Haïssaguerre Michel. Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur. Heart J. 2008 Oct;29 (19):2359–66. - PubMed
Publication types
LinkOut - more resources
Full Text Sources